Preventing Rebound-Associated Fractures after Discontinuation of Denosumab Therapy: A Position Statement from the Health Insurance Committee of the Korean Endocrine Society

Preventing Rebound-Associated Fractures after Discontinuation of Denosumab Therapy: A Position Statement from the Health Insurance Committee of the Korean Endocrine Society

Bibliographic Details
Main Authors: Bu Kyung Kim, Chong Hwa Kim, Yong-Ki Min
Format: Article
Language:English
Published: Academya Publishing Co. 2021-08-01
Series:Endocrinology and Metabolism
Online Access:http://www.e-enm.org/upload/pdf/enm-2021-1193.pdf
id doaj-2c22f927f0fb4a7eabd88c56ee3fd1c2
record_format Article
spelling doaj-2c22f927f0fb4a7eabd88c56ee3fd1c22021-09-03T00:03:20ZengAcademya Publishing Co.Endocrinology and Metabolism2093-596X2093-59782021-08-0136490991110.3803/EnM.2021.11932212Preventing Rebound-Associated Fractures after Discontinuation of Denosumab Therapy: A Position Statement from the Health Insurance Committee of the Korean Endocrine SocietyBu Kyung Kim0Chong Hwa Kim1Yong-Ki Min2 Department of Internal Medicine, Kosin University College of Medicine, Busan, Korea Division of Endocrinology and Metabolism, Department of Internal Medicine, Sejong General Hospital, Bucheon, Korea Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Koreahttp://www.e-enm.org/upload/pdf/enm-2021-1193.pdf
collection DOAJ
language English
format Article
sources DOAJ
author Bu Kyung Kim
Chong Hwa Kim
Yong-Ki Min
spellingShingle Bu Kyung Kim
Chong Hwa Kim
Yong-Ki Min
Preventing Rebound-Associated Fractures after Discontinuation of Denosumab Therapy: A Position Statement from the Health Insurance Committee of the Korean Endocrine Society
Endocrinology and Metabolism
author_facet Bu Kyung Kim
Chong Hwa Kim
Yong-Ki Min
author_sort Bu Kyung Kim
title Preventing Rebound-Associated Fractures after Discontinuation of Denosumab Therapy: A Position Statement from the Health Insurance Committee of the Korean Endocrine Society
title_short Preventing Rebound-Associated Fractures after Discontinuation of Denosumab Therapy: A Position Statement from the Health Insurance Committee of the Korean Endocrine Society
title_full Preventing Rebound-Associated Fractures after Discontinuation of Denosumab Therapy: A Position Statement from the Health Insurance Committee of the Korean Endocrine Society
title_fullStr Preventing Rebound-Associated Fractures after Discontinuation of Denosumab Therapy: A Position Statement from the Health Insurance Committee of the Korean Endocrine Society
title_full_unstemmed Preventing Rebound-Associated Fractures after Discontinuation of Denosumab Therapy: A Position Statement from the Health Insurance Committee of the Korean Endocrine Society
title_sort preventing rebound-associated fractures after discontinuation of denosumab therapy: a position statement from the health insurance committee of the korean endocrine society
publisher Academya Publishing Co.
series Endocrinology and Metabolism
issn 2093-596X
2093-5978
publishDate 2021-08-01
url http://www.e-enm.org/upload/pdf/enm-2021-1193.pdf
work_keys_str_mv AT bukyungkim preventingreboundassociatedfracturesafterdiscontinuationofdenosumabtherapyapositionstatementfromthehealthinsurancecommitteeofthekoreanendocrinesociety
AT chonghwakim preventingreboundassociatedfracturesafterdiscontinuationofdenosumabtherapyapositionstatementfromthehealthinsurancecommitteeofthekoreanendocrinesociety
AT yongkimin preventingreboundassociatedfracturesafterdiscontinuationofdenosumabtherapyapositionstatementfromthehealthinsurancecommitteeofthekoreanendocrinesociety
_version_ 1717818183866384384

Similar Items